Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation

Overview of attention for article published in European Journal of Pharmaceutics & Biopharmaceutics, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 2,690 followers.

RT @OtagoBiochemist: Latest publication with a contribution from Otago Biochemistry. Inhalable ceftazidime-roflumilast powder targeting inf…

Latest publication with a contribution from Otago Biochemistry. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumila… https://t.co/Nx0GsU8tgY

New publication from the Pletzer Laboratory! Titled: "Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation" Check out the full publication…

Latest publication with a contribution from Otago Biochemistry Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumila… https://t.co/Nx0GsTQk2Q

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.